Expression of the zinc transporter ZnT4 is decreased in the progression from early prostate disease to invasive prostate cancer

Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2

Dennis J. Slamon, Brian Leyland‐Jones, Steven Shak et al. · New England Journal of Medicine · 2001 · 11.5K citations · Full text

Medicine, Oncology, Pharmacology +10

Tissue microarrays for high-throughput molecular profiling of tumor specimens

Juha Kononen, Lukas Bubendorf, Anne Kallionimeni et al. · Nature Medicine · 1998 · 4.1K citations

Medicine, Molecular Biology, Oncology +11

Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

Peter McLaughlin, A.J. Grillo-López, Brian K. Link et al. · Journal of Clinical Oncology · 1998 · 2.8K citations

Pharmacy, Hematology, Immunology +17

Gene expression correlates of clinical prostate cancer behavior

Dinesh Singh, Phillip G. Febbo, Kenneth N. Ross et al. · Cancer Cell · 2002 · 2.5K citations · Full text

Life Sciences, Molecular Biology, Oncology +14

Prediction of Prognosis for Prostatic Adenocarcinoma by Combined Histological Grading and Clinical Staging

Donald F. Gleason, George T. Mellinger · The Journal of Urology · 1974 · 2.2K citations

Medicine, Oncology, Urology +15